HPV vaccination

Vaccination against human papilloma virus (HPV) reduces the risk of getting cervical cancer and is included in the Danish childhood immunisation programme.

There are three vaccines: Cervarix®, Gardasil® and Gardasil9®. The one used in the Danish childhood immunisation programme has varied over the years with the 4-valent Gardasil® from January 2009 to February 2016; the Cervarix® vaccine from February 2016 to 1 November 2017; and the Gardasil®9 vaccine from 1 November 2017. The vaccine used in the programme is decided based on a tender.

Summaries of product characteristics and package leaflets

It is a good idea to keep updated in the product information, which is available on the website of the European Medicines Agency:

Summary of product characteristics and package leaflet for Gardasil®

Summary of product characteristics and package leaflet for Gardasil9®

Summary of product characteristics and package leaflet for Cervarix®

The Danish Medicines Agency encourages doctors and citizens to continue to report suspected adverse reactions from HPV vaccination. You can report adverse reactions electronically on our website. To be able to monitor the safety of medicines in the best possible way, it is important that the information in the report is as complete as possible.

Fact sheet about HPV

Read more about HPV vaccines in our Fact sheet about the HPV vaccine and suspected adverse reactions (updated May 2017)